![Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-018-0426-8/MediaObjects/41409_2018_426_Fig2_HTML.png)
Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation
![Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-018-0426-8/MediaObjects/41409_2018_426_Fig1_HTML.png)
Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation
![Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF](https://i1.rgstatic.net/publication/366702994_Reduced_post-transplant_cyclophosphamide_doses_in_haploidentical_hematopoietic_cell_transplantation_for_elderly_patients_with_hematological_malignancies/links/63afb108097c7832ca7b2f4f/largepreview.png)
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF
![Biology of Blood and Marrow Transplantation | Abstracts from the 2016 BMT Tandem Meetings | ScienceDirect.com by Elsevier Biology of Blood and Marrow Transplantation | Abstracts from the 2016 BMT Tandem Meetings | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1083879115X00048-cov200h.gif)
Biology of Blood and Marrow Transplantation | Abstracts from the 2016 BMT Tandem Meetings | ScienceDirect.com by Elsevier
![National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report - Transplantation and Cellular Therapy, Official Publication of the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report - Transplantation and Cellular Therapy, Official Publication of the](https://www.astctjournal.org/cms/attachment/30e65a53-ac5f-4934-8728-285682532547/gr1_lrg.jpg)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report - Transplantation and Cellular Therapy, Official Publication of the
![Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ... Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...](https://www.astctjournal.org/cms/attachment/72374628-8a01-4d2e-b5de-ba3626704424/gr1_lrg.jpg)
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
![Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular ... Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular ...](https://www.astctjournal.org/cms/attachment/64667c09-1fc7-4d3e-80b3-550454ae856f/gr1_lrg.jpg)
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular ...
![Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/58f52e1d-77d6-4b2c-89d7-200eb5e9371a/ybbmt55141-fig-0001_lrg.jpg)
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
![Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome | Request PDF Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome | Request PDF](https://i1.rgstatic.net/publication/339956988_Prospective_evaluation_of_alternative_donor_from_unrelated_donor_and_cord_blood_in_adult_acute_leukemia_and_myelodysplastic_syndrome/links/5fb396b4299bf10c36862bda/largepreview.png)
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome | Request PDF
![Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-021-01286-x/MediaObjects/41409_2021_1286_Fig1_HTML.png)
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation
![The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation](https://media.springernature.com/lw703/springer-static/image/art%3A10.1038%2Fs41409-021-01342-6/MediaObjects/41409_2021_1342_Figa_HTML.png)
The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation
![Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society ... Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society ...](https://www.astctjournal.org/cms/attachment/96aa3bcb-bed3-4f13-b444-dcff2aa0ed56/gr1_lrg.jpg)